Ligand validation:6OP3

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6OP3_IMD_B_602	89%	54%	0.085	0.964	0.53	1.24	-	-	0	0	100%	1
6OP3_IMD_D_603	83%	68%	0.083	0.94	0.84	0.41	-	-	1	0	100%	1
6OP3_IMD_C_503	77%	70%	0.128	0.968	0.27	0.86	-	-	0	0	100%	1
6OP3_IMD_B_603	76%	61%	0.104	0.939	0.44	1.02	-	-	0	0	100%	1
6OP3_IMD_D_604	66%	71%	0.14	0.945	0.42	0.69	-	-	0	0	100%	1
6OP3_IMD_A_503	66%	73%	0.15	0.955	0.18	0.84	-	-	0	0	100%	1
6OP3_IMD_D_601	58%	73%	0.128	0.907	0.25	0.79	-	-	1	0	100%	1
6OP3_IMD_D_606	38%	71%	0.169	0.872	0.44	0.68	-	-	3	0	100%	1
6OP3_IMD_B_606	32%	71%	0.172	0.846	0.17	0.91	-	-	0	0	100%	1
6OP3_IMD_B_605	29%	64%	0.157	0.815	0.51	0.87	-	-	2	0	100%	1
6OP3_IMD_A_504	25%	65%	0.165	0.796	0.59	0.75	-	-	1	0	100%	1
6OP3_IMD_C_505	12%	54%	0.19	0.713	0.63	1.13	-	-	1	0	100%	1
6OP2_IMD_B_603	79%	76%	0.103	0.95	0.28	0.66	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
2ASN_IMD_X_202	99%	67%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1
3EBZ_IMD_B_301	99%	63%	0.059	0.99	0.35	1.03	-	-	0	0	100%	1
6LY4_IMD_A_502	99%	75%	0.059	0.989	0.23	0.73	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.